In his recent presentation at IDWeek 2024, Sean N. Tucker, PhD, Chief Scientific Officer and Vice President of Research at Vaxart, unveiled promising clinical trial results regarding VXA-GI.1-NN, a potential breakthrough in the prevention of Norovirus infections. Norovirus is a significant global health concern, known as a leading cause of acute gastroenteritis. Yet, the healthcare…